These observations highlight the clinical need for novel, accurate approaches to detect occult lymph node metastases in patients with colon cancer. GUCY2C is a biomarker whose expression normally ...

For example, positron emission tomography scanning has resulted in occult metastases being determined in ∼20% of patients with non-small-cell lung cancer. 10 If this and other imaging techniques ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

In most cases, it is not the original tumor that proves fatal, but the cancer spreading to other organs, a process called metastasis. This occurs when circulating tumor cells (CTCs) break away ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Representative index cases of various prostate cancer disease states are presented, including suspected high-risk disease, newly diagnosed treatment-naïve metastatic disease, suspected recurrent ...

RANO criteria for response assessment of brain metastases based on amino acid PET imaging. Nature Medicine , 2025; DOI: 10.1038/s41591-025-03633-7 Cite This Page : ...

The period of disease-free survival was defined as the interval from the date of diagnosis to locoregional recurrence, distant metastases, contralateral invasive breast cancer or ductal carcinoma ...

We previously reported prolonged progression-free survival and marginally prolonged overall survival among postmenopausal patients with hormone receptor–positive metastatic breast cancer who had ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be effective for patients with metastatic colorectal cancer (CRC) refractory to ...

TTX-MC138 is a first-in-class therapeutic candidate designed to inhibit microRNA-10b, or miR-10b, a microRNA widely believed to be critical to the emergence and progression of many metastatic cancers.